Core Scientific, Inc. (NASDAQ:CORZ) Stock Has Average Target Price of $30.32

Shares of Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) have earned an average recommendation of “Buy” from the twenty-two brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, seventeen have assigned a buy recommendation and three have given a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $30.32.

Several equities research analysts have recently issued reports on CORZ shares. Canaccord Genuity Group restated a “buy” rating and set a $36.00 price objective on shares of Core Scientific in a report on Thursday, October 15th. Craig Hallum reiterated a “buy” rating and issued a $25.00 target price on shares of Core Scientific in a research note on Friday, November 6th. Keefe, Bruyette & Woods upgraded Core Scientific from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $25.00 to $28.00 in a research report on Thursday, July 30th. Freedom Capital upgraded Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Finally, UBS Group reissued a “market outperform” rating on shares of Core Scientific in a research note on Wednesday, October 14th.

Get Our Latest Analysis on CORZ

Core Scientific Stock Performance

Shares of NASDAQ CORZ opened at $13.51 on Friday. Core Scientific has a 1 year low of $10.59 and a 1 year high of $30.46. The firm’s 50 day moving average price is $15.20 and its 200 day moving average price is $19.30. The firm has a market cap of $4.35 billion, a P/E ratio of 52.23 and a beta of 5.56.

Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of ($0.05) by $0.52. Core Scientific had a negative net margin of 18.31% and a negative return on equity of 70.05%. The firm had revenue of $232.87 million during the quarter, compared to analysts’ expectations of $196.54 million. As a group, equities analysts predict that Core Scientific will post 0.08 EPS for the current year.

Insider Activity at Core Scientific

In related news, insider Todd DuChene sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $12.78, for a total value of $127,800.00. Following the transaction, the insider owned 1,123,286 shares in the company, valued at approximately $14,355,595.08. This trade represents a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last quarter, insiders sold 100,000 shares of company stock valued at $1,553,400. Company insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Core Scientific

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Handelsbanken Fonder AB lifted its position in Core Scientific by 0.7% during the 2nd quarter. Handelsbanken Fonder AB now owns 94,500 shares of the company’s stock worth $2,418,000 after acquiring an additional 700 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Core Scientific by 34.5% during the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock valued at $78,000 after acquiring an additional 782 shares during the period. Parallel Advisors LLC boosted its holdings in Core Scientific by 125.0% during the third quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock valued at $29,000 after acquiring an additional 1,000 shares during the period. Parkside Financial Bank & Trust grew its position in shares of Core Scientific by 1,371.3% in the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock valued at $30,000 after purchasing an additional 1,097 shares during the last quarter. Finally, Carronade Capital Management LP grew its position in shares of Core Scientific by 1.1% in the first quarter. Carronade Capital Management LP now owns 101,103 shares of the company’s stock valued at $1,513,000 after purchasing an additional 1,103 shares during the last quarter.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc. is a U.S.-based digital infrastructure company that operates data centers and provides computing services. Its business includes mining bitcoin, which involves using specialized computers to help process transactions and secure the Bitcoin network, as well as hosting equipment for third-party mining customers. The company also provides data center infrastructure for high-performance computing workloads, including artificial intelligence applications. Its facilities and services are designed to support the power, cooling, and computing needs of these operations.

Featured Articles

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.